FUJOVEE
Live / Allowed — Fourth extension granted (statement of use) (as of 30 May 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 Nov 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97688927
- Mark type
- Design + words
- Filed
- 22 Nov 2022
- Published for opposition
- 10 Oct 2023
- Attorney of record
- Lindsay J. Hulley
Goods and services
- Class 005 — Pharmaceuticals: Orally delivered pharmaceutical preparations for the prevention and treatment of COVID-19, Coronaviruses and cancer
Owner
- VIVASOR, INC., SAN DIEGO, CA, US
- Sorrento Therapeutics, Inc., San Diego, CA, US
- Sorrento Therapeutics, Inc., San Diego, CA, US
Board proceedings on this mark
- Extension of Time to Oppose No. 97688927 — TEVA PHARMACEUTICALS INTERNATIONAL GMBH v. Sorrento Therapeutics, Inc., filed 06 Nov 2023 (Terminated)
Prosecution history
- 30 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 May 2026 — SOU EXTENSION 4 GRANTED
- 29 May 2026 — SOU EXTENSION 4 FILED
- 29 May 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Dec 2025 — SOU EXTENSION 3 GRANTED
- 03 Dec 2025 — SOU EXTENSION 3 FILED
- 03 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 May 2025 — SOU EXTENSION 2 GRANTED
- 30 May 2025 — SOU EXTENSION 2 FILED
- 30 May 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2024 — SOU EXTENSION 1 GRANTED
- 18 Jun 2024 — SOU EXTENSION 1 FILED